framycetin has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bara, H; Sambanis, A | 1 |
| Carvajal-Aldaz, DG; Coulon, D; Durham, HA; Gauthier, T; Geaghan, J; Guice, JL; Husseneder, C; Janes, M; Keenan, MJ; Martin, RJ; Page, RC; Raggio, AM | 1 |
2 other study(ies) available for framycetin and glucagon-like peptide 1
| Article | Year |
|---|---|
Insulin-secreting L-cells for the treatment of insulin-dependent diabetes.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cell Line; Colforsin; Diabetes Mellitus; Drug Resistance; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Neomycin; Proinsulin; Transfection | 2008 |
Simultaneous delivery of antibiotics neomycin and ampicillin in drinking water inhibits fermentation of resistant starch in rats.
Topics: Abdominal Fat; Ampicillin; Animals; Anti-Bacterial Agents; Cecum; Diet, High-Fat; Digestion; Drinking Water; Drug Interactions; Fermentation; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Hydrogen-Ion Concentration; Male; Neomycin; Rats, Sprague-Dawley; Starch | 2017 |